Global Dengue Vaccines Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

According to our (Global Info Research) latest study, the global Dengue Vaccines market size was valued at US$ 477 million in 2023 and is forecast to a readjusted size of USD 1179 million by 2030 with a CAGR of 14.0% during review period.

The only one version which is commercially available now, known as Dengvaxia and produced by Sanofi, don't has enough efficacy. While there are several vaccines are on trial now. TAK-003, developed by Takeda is one stride closer to reaching the sizable market waiting for dengue vaccines as it reports positive top-line results from a massive Phase III trial.

This report is a detailed and comprehensive analysis for global Dengue Vaccines market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Dengue Vaccines market size and forecasts, in consumption value ($ Million), 2019-2030
Global Dengue Vaccines market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Dengue Vaccines market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Dengue Vaccines market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Dengue Vaccines
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Dengue Vaccines market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Takeda, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Dengue Vaccines market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Dengvaxia
    TAK-003
    Others

Market segment by Application
    Public Sector
    Private Sector

Market segment by players, this report covers
    Sanofi
    Takeda

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Dengue Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Dengue Vaccines, with revenue, gross margin, and global market share of Dengue Vaccines from 2019 to 2024.
Chapter 3, the Dengue Vaccines competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Dengue Vaccines market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Vaccines.
Chapter 13, to describe Dengue Vaccines research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Dengue Vaccines by Type
        1.3.1 Overview: Global Dengue Vaccines Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Dengue Vaccines Consumption Value Market Share by Type in 2023
        1.3.3 Dengvaxia
        1.3.4 TAK-003
        1.3.5 Others
    1.4 Global Dengue Vaccines Market by Application
        1.4.1 Overview: Global Dengue Vaccines Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Public Sector
        1.4.3 Private Sector
    1.5 Global Dengue Vaccines Market Size & Forecast
    1.6 Global Dengue Vaccines Market Size and Forecast by Region
        1.6.1 Global Dengue Vaccines Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Dengue Vaccines Market Size by Region, (2019-2030)
        1.6.3 North America Dengue Vaccines Market Size and Prospect (2019-2030)
        1.6.4 Europe Dengue Vaccines Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Dengue Vaccines Market Size and Prospect (2019-2030)
        1.6.6 South America Dengue Vaccines Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Dengue Vaccines Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Dengue Vaccines Product and Solutions
        2.1.4 Sanofi Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Sanofi Recent Developments and Future Plans
    2.2 Takeda
        2.2.1 Takeda Details
        2.2.2 Takeda Major Business
        2.2.3 Takeda Dengue Vaccines Product and Solutions
        2.2.4 Takeda Dengue Vaccines Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Takeda Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Dengue Vaccines Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Dengue Vaccines by Company Revenue
        3.2.2 Top 3 Dengue Vaccines Players Market Share in 2023
        3.2.3 Top 6 Dengue Vaccines Players Market Share in 2023
    3.3 Dengue Vaccines Market: Overall Company Footprint Analysis
        3.3.1 Dengue Vaccines Market: Region Footprint
        3.3.2 Dengue Vaccines Market: Company Product Type Footprint
        3.3.3 Dengue Vaccines Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Dengue Vaccines Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Dengue Vaccines Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Dengue Vaccines Consumption Value Market Share by Application (2019-2024)
    5.2 Global Dengue Vaccines Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Dengue Vaccines Consumption Value by Type (2019-2030)
    6.2 North America Dengue Vaccines Market Size by Application (2019-2030)
    6.3 North America Dengue Vaccines Market Size by Country
        6.3.1 North America Dengue Vaccines Consumption Value by Country (2019-2030)
        6.3.2 United States Dengue Vaccines Market Size and Forecast (2019-2030)
        6.3.3 Canada Dengue Vaccines Market Size and Forecast (2019-2030)
        6.3.4 Mexico Dengue Vaccines Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Dengue Vaccines Consumption Value by Type (2019-2030)
    7.2 Europe Dengue Vaccines Consumption Value by Application (2019-2030)
    7.3 Europe Dengue Vaccines Market Size by Country
        7.3.1 Europe Dengue Vaccines Consumption Value by Country (2019-2030)
        7.3.2 Germany Dengue Vaccines Market Size and Forecast (2019-2030)
        7.3.3 France Dengue Vaccines Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Dengue Vaccines Market Size and Forecast (2019-2030)
        7.3.5 Russia Dengue Vaccines Market Size and Forecast (2019-2030)
        7.3.6 Italy Dengue Vaccines Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Dengue Vaccines Market Size by Region
        8.3.1 Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2030)
        8.3.2 China Dengue Vaccines Market Size and Forecast (2019-2030)
        8.3.3 Japan Dengue Vaccines Market Size and Forecast (2019-2030)
        8.3.4 South Korea Dengue Vaccines Market Size and Forecast (2019-2030)
        8.3.5 India Dengue Vaccines Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Dengue Vaccines Market Size and Forecast (2019-2030)
        8.3.7 Australia Dengue Vaccines Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Dengue Vaccines Consumption Value by Type (2019-2030)
    9.2 South America Dengue Vaccines Consumption Value by Application (2019-2030)
    9.3 South America Dengue Vaccines Market Size by Country
        9.3.1 South America Dengue Vaccines Consumption Value by Country (2019-2030)
        9.3.2 Brazil Dengue Vaccines Market Size and Forecast (2019-2030)
        9.3.3 Argentina Dengue Vaccines Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Dengue Vaccines Market Size by Country
        10.3.1 Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2030)
        10.3.2 Turkey Dengue Vaccines Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Dengue Vaccines Market Size and Forecast (2019-2030)
        10.3.4 UAE Dengue Vaccines Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Dengue Vaccines Market Drivers
    11.2 Dengue Vaccines Market Restraints
    11.3 Dengue Vaccines Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Dengue Vaccines Industry Chain
    12.2 Dengue Vaccines Upstream Analysis
    12.3 Dengue Vaccines Midstream Analysis
    12.4 Dengue Vaccines Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Dengue Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Sanofi Company Information, Head Office, and Major Competitors
 Table 6. Sanofi Major Business
 Table 7. Sanofi Dengue Vaccines Product and Solutions
 Table 8. Sanofi Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Sanofi Recent Developments and Future Plans
 Table 10. Takeda Company Information, Head Office, and Major Competitors
 Table 11. Takeda Major Business
 Table 12. Takeda Dengue Vaccines Product and Solutions
 Table 13. Takeda Dengue Vaccines Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Takeda Recent Developments and Future Plans
 Table 15. Global Dengue Vaccines Revenue (USD Million) by Players (2019-2024)
 Table 16. Global Dengue Vaccines Revenue Share by Players (2019-2024)
 Table 17. Breakdown of Dengue Vaccines by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 18. Market Position of Players in Dengue Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 19. Head Office of Key Dengue Vaccines Players
 Table 20. Dengue Vaccines Market: Company Product Type Footprint
 Table 21. Dengue Vaccines Market: Company Product Application Footprint
 Table 22. Dengue Vaccines New Market Entrants and Barriers to Market Entry
 Table 23. Dengue Vaccines Mergers, Acquisition, Agreements, and Collaborations
 Table 24. Global Dengue Vaccines Consumption Value (USD Million) by Type (2019-2024)
 Table 25. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
 Table 26. Global Dengue Vaccines Consumption Value Forecast by Type (2025-2030)
 Table 27. Global Dengue Vaccines Consumption Value by Application (2019-2024)
 Table 28. Global Dengue Vaccines Consumption Value Forecast by Application (2025-2030)
 Table 29. North America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
 Table 30. North America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
 Table 31. North America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
 Table 32. North America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
 Table 33. North America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
 Table 34. North America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
 Table 35. Europe Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
 Table 36. Europe Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
 Table 37. Europe Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
 Table 38. Europe Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
 Table 39. Europe Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
 Table 40. Europe Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
 Table 41. Asia-Pacific Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
 Table 42. Asia-Pacific Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
 Table 43. Asia-Pacific Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
 Table 44. Asia-Pacific Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
 Table 45. Asia-Pacific Dengue Vaccines Consumption Value by Region (2019-2024) & (USD Million)
 Table 46. Asia-Pacific Dengue Vaccines Consumption Value by Region (2025-2030) & (USD Million)
 Table 47. South America Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
 Table 48. South America Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
 Table 49. South America Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
 Table 50. South America Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
 Table 51. South America Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
 Table 52. South America Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
 Table 53. Middle East & Africa Dengue Vaccines Consumption Value by Type (2019-2024) & (USD Million)
 Table 54. Middle East & Africa Dengue Vaccines Consumption Value by Type (2025-2030) & (USD Million)
 Table 55. Middle East & Africa Dengue Vaccines Consumption Value by Application (2019-2024) & (USD Million)
 Table 56. Middle East & Africa Dengue Vaccines Consumption Value by Application (2025-2030) & (USD Million)
 Table 57. Middle East & Africa Dengue Vaccines Consumption Value by Country (2019-2024) & (USD Million)
 Table 58. Middle East & Africa Dengue Vaccines Consumption Value by Country (2025-2030) & (USD Million)
 Table 59. Global Key Players of Dengue Vaccines Upstream (Raw Materials)
 Table 60. Global Dengue Vaccines Typical Customers


List of Figures
 Figure 1. Dengue Vaccines Picture
 Figure 2. Global Dengue Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Dengue Vaccines Consumption Value Market Share by Type in 2023
 Figure 4. Dengvaxia
 Figure 5. TAK-003
 Figure 6. Others
 Figure 7. Global Dengue Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Dengue Vaccines Consumption Value Market Share by Application in 2023
 Figure 9. Public Sector Picture
 Figure 10. Private Sector Picture
 Figure 11. Global Dengue Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Dengue Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Market Dengue Vaccines Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 14. Global Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
 Figure 15. Global Dengue Vaccines Consumption Value Market Share by Region in 2023
 Figure 16. North America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 17. Europe Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 18. Asia-Pacific Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 19. South America Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 20. Middle East & Africa Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 21. Company Three Recent Developments and Future Plans
 Figure 22. Global Dengue Vaccines Revenue Share by Players in 2023
 Figure 23. Dengue Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 24. Market Share of Dengue Vaccines by Player Revenue in 2023
 Figure 25. Top 3 Dengue Vaccines Players Market Share in 2023
 Figure 26. Top 6 Dengue Vaccines Players Market Share in 2023
 Figure 27. Global Dengue Vaccines Consumption Value Share by Type (2019-2024)
 Figure 28. Global Dengue Vaccines Market Share Forecast by Type (2025-2030)
 Figure 29. Global Dengue Vaccines Consumption Value Share by Application (2019-2024)
 Figure 30. Global Dengue Vaccines Market Share Forecast by Application (2025-2030)
 Figure 31. North America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
 Figure 32. North America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
 Figure 33. North America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
 Figure 34. United States Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 35. Canada Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 36. Mexico Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 37. Europe Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
 Figure 38. Europe Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
 Figure 39. Europe Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
 Figure 40. Germany Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 41. France Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 42. United Kingdom Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 43. Russia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 44. Italy Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 45. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
 Figure 46. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
 Figure 47. Asia-Pacific Dengue Vaccines Consumption Value Market Share by Region (2019-2030)
 Figure 48. China Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 49. Japan Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 50. South Korea Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 51. India Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 52. Southeast Asia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 53. Australia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 54. South America Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
 Figure 55. South America Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
 Figure 56. South America Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
 Figure 57. Brazil Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 58. Argentina Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 59. Middle East & Africa Dengue Vaccines Consumption Value Market Share by Type (2019-2030)
 Figure 60. Middle East & Africa Dengue Vaccines Consumption Value Market Share by Application (2019-2030)
 Figure 61. Middle East & Africa Dengue Vaccines Consumption Value Market Share by Country (2019-2030)
 Figure 62. Turkey Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 63. Saudi Arabia Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 64. UAE Dengue Vaccines Consumption Value (2019-2030) & (USD Million)
 Figure 65. Dengue Vaccines Market Drivers
 Figure 66. Dengue Vaccines Market Restraints
 Figure 67. Dengue Vaccines Market Trends
 Figure 68. Porters Five Forces Analysis
 Figure 69. Dengue Vaccines Industrial Chain
 Figure 70. Methodology
 Figure 71. Research Process and Data Source

Companies Mentioned

Sanofi
Takeda